West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 748,800 | 746,900 | 702,100 | 695,400 | 732,000 |
| Cost of Goods | 475,200 | 482,200 | 472,100 | 465,200 | 453,800 |
| Gross Profit | 273,600 | 264,700 | 230,000 | 230,200 | 278,200 |
| Operating Expenses | 114,200 | 103,600 | 103,900 | 107,600 | 118,100 |
| Operating Income | 159,600 | 161,300 | 126,200 | 122,800 | 160,900 |
| Interest Expense | -800 | 700 | 1,500 | 1,600 | 1,200 |
| Other Income | 6,500 | 7,800 | 8,500 | 10,500 | 11,800 |
| Pre-tax Income | 166,900 | 168,400 | 133,200 | 131,700 | 171,500 |
| Income Tax | 36,800 | 32,400 | 21,900 | 16,400 | 34,500 |
| Net Income Continuous | 130,100 | 136,000 | 111,300 | 115,300 | 137,000 |
| Net Income | $130,100 | $136,000 | $111,300 | $115,300 | $137,000 |
| EPS Basic Total Ops | 1.79 | 1.87 | 1.52 | 1.57 | 1.85 |
| EPS Basic Continuous Ops | 1.79 | 1.87 | 1.52 | 1.57 | 1.85 |
| EPS Diluted Total Ops | 1.78 | 1.85 | 1.51 | 1.55 | 1.83 |
| EPS Diluted Continuous Ops | 1.77 | 1.85 | 1.51 | 1.55 | 1.83 |
| EPS Diluted Before Non-Recurring Items | 1.82 | 1.85 | 1.52 | N/A | N/A |
| EBITDA(a) | $200,300 | $201,500 | $165,100 | $158,400 | $196,800 |